Renalytix (Reg S) - Overview

RenalytixAI is a developer of artificial intelligence (AI) enabled clinical decision support solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAIÂ’s solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care and patient stratification for drug clinical trials.

Registrars:

Key Personnel

CEO: James Renwick McCullough
Chief Technical Officer: Fergus Fleming
Non-Executive Chairman: Christopher H B Mills
Non-Executive Director: Erik Kristian Lium, Catherine Coste, Robert (Rob) Graham Naylor

Contact Details

Address: 2 Leman Street, London, United Kingdom
Phone:
Fax:
Website: http://www.renalytix.com/
Email:

Listings

ISIN: GB00BYWL4Y04
Sector: Pharma and Biotech, Pharma and Biotech
Main Indices: FTSE AIM All-Share